News on everything: from our latest technology developments to new partnerships and publications.
Next Generation Lyme Diagnostics: Multi-Peptide Approach
Lyme Borreliosis, commonly known as Lyme disease, poses a significant health threat worldwide. The condition stems from infection by the bacterial spe
08 April, 2024
Point-of-care and screening tests for early detection of Type 1 Diabetes
EpitogenX is delighted to announce the launch of an Innovate UK Knowledge Transfer Partnership (KTP) between our subsidiary, Vertebrate Antibodies, an
08 September, 2023
EpitoPredikt® and EpitoGen® combine to develop a diagnostic test for Lyme Disease (LD)
The diagnostic pathway in the UK follows a two-step approach using commonly available antibody screening tests. This process is lengthy, complex, expe
02 March, 2023